Table of Contents
Definition / general | Essential features | Terminology | ICD coding | Epidemiology | Sites | Pathophysiology | Etiology | Clinical features | Radiology description | Radiology images | Prognostic factors | Case reports | Treatment | Gross description | Gross images | Microscopic (histologic) description | Microscopic (histologic) images | Cytology description | Cytology images | Positive stains | Negative stains | Electron microscopy description | Electron microscopy images | Molecular / cytogenetics description | Sample pathology report | Differential diagnosis | Board review style question #1 | Board review style answer #1 | Board review style question #2 | Board review style answer #2 | Board review style question #3 | Board review style answer #3Cite this page: Zhao X, Wei S. Anaplastic. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/thyroidUndiff.html. Accessed March 22nd, 2023.
Definition / general
- A highly aggressive thyroid malignancy composed of undifferentiated follicular thyroid cells (Lloyd: WHO Classification of Tumours of Endocrine Organs, 4th Edition, 2017)
- 1 - 1.7% of all thyroid cancers in the United States
- Geographical prevalence ranges from 1.3 - 9.8% and the incidence is decreasing worldwide, accounting for up to 50% of thyroid cancer mortality (Oral Oncol 2013;49:702, Clin Oncol (R Coll Radiol) 2010;22:486, J Oncol 2011;2011:542358)
- Rapidly enlarging, bulky neck mass invades adjacent structures causing hoarseness, dysphagia, dyspnea
- Most thyroid sarcoma-like tumors are probably anaplastic carcinomas; small cell types reported in past were probably lymphoma or variants of medullary or insular carcinoma (Am J Clin Pathol 1985;83:135)
- Paucicellular variant: uncommon; resembles Riedel thyroiditis; may be due to extensive infarction
- Rhabdoid variant: very rare; aggressive, often metastasizes; to date, always rapidly fatal
Essential features
- Highly aggressive thyroid carcinoma composed of undifferentiated follicular cells that demonstrate immunohistochemical or ultrastructural features of epithelial differentiation but devoid of morphologic and immunophenotypic markers of thyroid origin
Terminology
- Undifferentiated thyroid carcinoma, carcinosarcoma, sarcomatoid carcinoma, metaplastic carcinoma, spindle cell carcinoma, giant cell carcinoma, pleomorphic carcinoma
ICD coding
Epidemiology
- Medium age 60 - 70 years with incidence to rise with age, F:M = 2:1 (Ann Surg Oncol 2007;14:3011)
- Higher incidence in areas of dietary iodine deficiency
- Median 1 year survival rate: 10 - 20%
- Rhabdoid variant: usually women, mean 56 years, range 42 - 67 years
Sites
- Thyroid gland: rare cases from ectopic thyroid tissue were reported (Int J Gynecol Pathol 2014;33:607, Int J Gynecol Pathol 2016;35:357)
- Often presents with local invasion and metastatic spread to regional lymph nodes and distant sites
- All are considered high stage (IV) tumor (J Oncol 2011;2011:542358)
- Stage IVA and IVB patients have intrathyroidal tumors (IVA) and extrathyroidal tumors (IVB), whereas stage IVC patients have distant metastasis
Pathophysiology
- May arise as anaplastic transformation of differentiated thyroid carcinoma (papillary, follicular or Hürthle cell carcinoma)
- Most cases have a core of conserved mutations in well differentiated and anaplastic areas, plus increases in mutation rates in anaplastic areas (Am J Surg Pathol 2003;27:1559)
Etiology
- Unclear, may be associated with radiation and iodine deficiency
- Coexisting well differentiated thyroid carcinomas in 22 - 78% of cases
Clinical features
- 25 - 50% have prior multinodular goiter, 20% have prior differentiated carcinoma, 20% have concurrent differentiated carcinoma
- Rapidly enlarging, painful, firm, ill defined, lower anterior neck mass usually fixed to the underlying structures
- Local invasion of the surrounding structures occurs in almost 70% of patients: muscles (65%), trachea (46%), esophagus (44%), laryngeal nerve (27%) and larynx (13%)
- Hoarseness, dyspnea and dysphagia as compressive symptoms
- Extrathyroidal extension in majority of cases
- Regional nodal metastases and vocal cord paralysis present in up to 40% and 30%, respectively (Int J Surg 2014;12:S170)
- Up to 75% of patients have distant metastases (lung [80%], bone [6 - 15%] and brain [5 - 13%])
Radiology description
- Ultrasonography:
- Solid masses, marked hypoechogenicity, irregular margin, internal calcification, wider than tall shape and cervical lymph node involvement (Yonsei Med J 2013;54:1400)
- Computed tomography scan:
- Large isodense or slightly hyperdense masses relative to skeletal muscle, calcification and necrosis (AJR Am J Roentgenol 1990;154:1079)
- Magnetic resonance imaging:
- Useful to assess tumor extension, particularly in the esophagus musculature, trachea and carotid vessel
- F-fluorodeoxyglucose positron emission tomography (FDG-PET):
- Staging assessment due to its enhanced expression of glucose transporter (GLUT1), resulting in increased glucose uptake (AME Case Rep 2018;2:20)
Prognostic factors
- Median survival is 4 months with a 1 year survival rate of 10 - 20% (J Oncol 2011:542358)
- Quality of resection is a significant prognostic factor for survival (Crit Rev Oncol Hematol 2013;86:290, Cancer 2001;91:2335)
- Favorable prognostic indicators are:
- Younger age (≤ 60 years old)
- Absence of cervical or distant metastases
- Small tumors (≤ 5 - 7 cm)
- Unilateral tumors
- Absence of local invasion of the surrounding tissue
- Incidental finding of anaplastic thyroid carcinoma within a thyroidectomy specimen (Langenbecks Arch Surg 2005;390:203, World J Surg 2012;36:1247, Ann Surg Oncol 2008;15:2500, Head Neck 2007;29:765)
Case reports
- 34 year old man and 39 year old woman with tumors associated with hereditary nonpolyposis colorectal cancer syndrome (Mod Pathol 2004;17:981)
- 35 year old woman with survival > 3 years (Endocr Regul 2007;41:41)
- 38 year old woman with disseminated struma ovarii containing focal anaplastic carcinoma (Int J Gynecol Pathol 2014;33:607)
- 54 year old woman with progressively enlarging thyroid mass (Ann Oncol 2000;11:1497)
- 62 year old woman with follicular carcinoma with pleomorphic spindle cell tumor (Ann Endocrinol (Paris) 2006;67:64)
- 65 year old man with a long term survival (Eur Rev Med Pharmacol Sci 2014;18:1368)
- 67 year old woman with chronic goiter and rapidly growing mass (Arch Pathol Lab Med 2005;129:e55)
- 68 year old man with minimally invasive thyroid anaplastic carcinoma (Turk J Surg 2018;34:319)
- 69 year old man with neck mass (University of Pittsburgh Case #466)
- 70 year old man with diffuse large B cell lymphoma misdiagnosed as anaplastic carcinoma (Cytojournal 2006;3:23)
- 72 year old man with anaplastic thyroid carcinoma presenting with gastric metastasis (Hippokratia 2015;19:85)
- 74 year old woman with anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma (Endocrinol Diabetes Metab Case Rep 2019;2019:19)
- 79 year old woman with anaplastic thyroid carcinoma arising from chronic hyperthyroidism (Case Rep Endocrinol 2018:7261264)
- 82 year old woman with metastatic anaplastic carcinoma diagnosed by FNA (Diagn Cytopathol 2014;42:694)
- Follicular carcinoma with osteosarcoma / chondrosarcoma (Arch Pathol Lab Med 1987;111:1169)
- Anaplastic thyroid carcinomas incidentally found on postoperative pathological examination (World J Surg 2014;38:2311)
Treatment
- Radiation therapy, surgery when feasible or chemoradiation either concurrently or sequentially (J Oncol 2011;2011:542358)
- EGFR, VEGFR and ALK alteration may be used for targeted therapy
- Some cases may express PD-L1 (Oncologist 2017;22:1149)
Gross description
- Bulky solid mass (mean: 6 cm) with zones of homogeneous and necrosis or variegated appearance (Crit Rev Oncol Hematol 2013;86:290)
- On cut section, light tan and fleshy with zones of necrosis and hemorrhage
- Infiltrating, often into adjacent soft tissues and organs
- Paucicellular variant: hard fibrotic mass
Gross images
Microscopic (histologic) description
- Common features include widely invasive growth, extensive tumor necrosis, marked nuclear pleomorphism and high mitotic activity
- Three patterns (can be singly or in any combination):
- Sarcomatoid (about 50%): malignant spindle cells resembling high grade pleomorphic sarcoma
- Giant cell (30 - 40%): highly pleomorphic tumor cells with marked nuclear hyperchromasia and some tumor giant cells, may have cavernous blood filled sinuses resembling aneurysmal bone cyst and angiosarcoma (Am J Surg Pathol 1991;15:160)
- Multiple small intracytoplasmic hyaline globules have been described
- Epithelial (< 20%): squamoid / squamous tumor nests with abundant dense eosinophilic cytoplasm resembling nonkeratinizing squamous cell carcinoma of the lung or upper aerodigestive tract and occasional focal keratinization
- Necrosis
- Vascular invasion with obliteration of the lumen
- Increased mitotic figures
- Heterologous differentiation: neoplastic bone and cartilage
- Secondary change: acute inflammation, macrophages, osteoclast-like multinucleated giant cells (PLoS One 2011;6:e22567, Endocr Relat Cancer 2008;15:1069)
- Microscopic variants:
- Paucicellular (< 1%): infiltrative, composed of acellular or necrotic fibrous tissue with hypocellular foci of mildly atypical spindle cells obliterating large blood vessels, mixed with collagen and small lymphocytes (Am J Clin Pathol 1996;105:388)
- Rhabdoid: more prevalent in patients who had received chemotherapy (Endocr J 2016;63:441)
- Highly cellular, solid infiltrative growth with extracapsular invasion
- Tumor cells are large and pleomorphic with abundant cytoplasm, eosinophilic inclusions, eccentric nuclei with distinct nucleoli (Am J Surg Pathol 2007;31:729)
- Typically strongly positive for vimentin and low molecular weight cytokeratin but are negative for thyroglobulin
- Small cell: extremely rare, behaves differently than other anaplastic carcinomas and most may be able to be reclassified as lymphoma, medullary carcinoma or poorly differentiated thyroid carcinomas (Am J Clin Pathol 1985;83:135, Virchows Arch A Pathol Anat Histopathol 1984;404:117)
Microscopic (histologic) images
Contributed by Shuanzeng Wei, M.D., Ph.D.
Contributed by Stephen J. Schultenover, M.D.
AFIP images
Cytology description
- High grade pleomorphic tumor cells, neoplastic giant cells, spindle cells or squamoid cells in a background of tumor diathesis and inflammation
Cytology images
Positive stains
- PAX8 (79%); variable EMA and CEA (Mod Pathol 2008;21:192)
- Keratin (not in sarcomatoid variants), vimentin (spindle cell component); p53 (well differentiated tumor is usually p53-); increased Ki67 and PCNA (Am J Clin Pathol 1991;96:15, Am J Clin Pathol 2006;125:399)
- Paucicellular variant: EMA, cytokeratin, p53
- Rhabdoid variant: vimentin, actin, myoglobin, cytokeratin
Negative stains
- Calcitonin, thyroglobulin, TTF1 (can be focally positive in the squamoid area)
- Paucicellular variant: thyroglobulin (Endocr Pathol 2001;12:157)
- Rhabdoid variant: desmin, thyroglobulin, calcitonin
Electron microscopy description
- No junctional complexes or obvious epithelial elements in osteoclast-like giant cells (Am J Surg Pathol 1978;2:401)
- Rhabdoid variant: whorled cytoplasmic filaments
Electron microscopy images
Molecular / cytogenetics description
- Highest mutation burden among all thyroid malignancy
- Ninefold higher median number of nonsynonymous somatic mutations than well differentiated papillary carcinoma (Endocr Relat Cancer 2008;15:1069)
- TP53 mutation in 30 - 70% cases
- BRAF V600E: 20%
- RAS family mutation (NRAS, HRAS and KRAS)
- Others alterations: TERT (70%) PIK3CA (10 - 20%), PTEN (10 - 15%) and ALK
- Mutations commonly found in well differentiated papillary and follicular carcinomas, such as RET / PTC and PAX8 / PPARG fusions, are rare
Sample pathology report
- Thyroid, total thyroidectomy:
- Anaplastic thyroid carcinoma, spindle cell pattern, 8.4 cm, with extensive extrathyroid extension involving skeletal muscle and nerves (see comment)
- Extensive lymphovascular invasion identified
- Metastatic carcinoma in 2 out of 4 lymph nodes (2/4)
- Comment: Immunohistochemistry performed on block 1A with adequate controls show that the tumor cells are positive for PAX8 and CK7 and the tumor cells are negative for thyroglobulin and TTF1. The morphologic and immunochemical findings support the above diagnosis.
Differential diagnosis
- Angiosarcoma:
- No concurrent differentiated thyroid carcinoma
- Can be keratin+
- Anaplastic carcinoma can be endothelial marker+
- Large cell lymphoma:
- Medullary thyroid carcinoma:
- Tumor cells have granular cytoplasm and finely stippled chromatin, calcitonin+ with amyloid
- Metastatic carcinoma to thyroid:
- Pertinent tumor history
- Poorly differentiated thyroid carcinoma:
- Nests of monotonous cells without pleomorphic tumor cells, thyroglobulin+, TTF1+
- Squamous cell thyroid carcinoma:
- Entirely squamous cell carcinoma
- Riedel thyroiditis:
- Paucicellular variant has atypical keratin+ spindle cells, necrosis and tumor obliteration of blood vessels
Board review style question #1
Board review style answer #1
D. PAX8+, thyroglobulin+, TTF1+.
Anaplastic thyroid carcinoma can be PAX8+ in more than 50% cases; however, this tumor is generally negative for thyroglobulin and TTF1.
Reference: Anaplastic carcinoma
Comment Here
Reference: Anaplastic carcinoma
Comment Here
Board review style question #2
- Which of the following immunohistochemical markers is most useful to differentiate anaplastic thyroid carcinoma from metastasis?
- Cytokeratin
- PAX8
- p63
- Thyroglobulin
- TTF1
Board review style answer #2
B. PAX8+. Common thyroid lineage markers such as TTF1 and thyroglobulin are usually absent in anaplastic thyroid carcinoma, whereas PAX8+ is retained in more than 50% cases and may be utilized to differentiate from metastasis.
Reference: Anaplastic carcinoma
Comment Here
Reference: Anaplastic carcinoma
Comment Here
Board review style question #3
- Which of the following gene mutations / alterations are not usually identified in anaplastic thyroid carcinoma?
- BRAF V600E
- PAX8 / PPAR
- PIK3CA
- RAS
- TP53
Board review style answer #3
B. PAX8 / PPAR. Mutations commonly found in well differentiated papillary and follicular carcinomas, such as RET / PTC and PAX8 / PPARG fusions, are rare in anaplastic thyroid carcinoma.
Reference: Anaplastic carcinoma
Comment Here
Reference: Anaplastic carcinoma
Comment Here